Subscribe to RSS
DOI: 10.1055/s-2001-15448
In Vivo Neurotransmitter Release in the Locus Coeruleus - Effects of Hyperforin, Inescapable Shock and Fear
Publication History
Publication Date:
31 December 2001 (online)
Hyperforin, the main antidepressant constituent of Hypericum perforatum, influences the extracellular concentrations of transmitters in vitro and in vivo. In vivo experiments have shown that hyperforin enhances the extracellular concentrations of dopamine, norepinephrine, serotonin and glutamate in the locus coeruleus. Hyperforin-free Hypericum extract also elevates the extracellular concentrations of dopamine and norepinephrine in the locus coeruleus, but, in contrast to hyperforin, the extracellular concentration of serotonin is diminished. The differing profiles of hyperforin and hyperforin-free Hypericum extract on the extracellular transmitter concentrations point to the presence of an additional biologically active compound in Hypericum perforatum. Inescapable shock increases the release of monoamines and several amino acids, as well as motility, blood pressure and heart rate. Conditioned fear, similar to hyperforin-free Hypericum extract, decreases the release of serotonin in the locus coeruleus. Conditioned fear also leads to tachycardia. The latter finding shows that telemetric heart rate recording is a good index for conditioned fear. In vivo findings confirm the idea that the anti-depressive properties of Hypericum extract and hyperforin result from increases in extracellular neurotransmitter concentrations. Since hyperforin-free extract, like conditioned fear, reduces the extracellular concentration of serotonin, hyperforin may be more beneficial than Hypericum extract in the treatment of depressive disorders.
References
- 1 Benveniste H. Brain microdialysis. J Neurochem . 1989; 52 1667-1679
- 2 Bremmer J D, JH Krystal SM Southwick D S. Charney: Noradrenergic mechanisms in stress and anxiety. Synapse. 1996; 23 28-38
- 3 Chatterjee S S, Bhattacharya S K, Wonnemann M, Singer A, Müller W E. Hyperforin as a possible antidepressant component of hypericum extracts. Life Sci. 1998; 63 499-510
- 4 Di Chiara G, Tanda G, Carboni E. Estimation of in vivo neurotransmitter release by brain microdialysis: the issue of validity. Behav Pharmacol. 1996; 7 640-657
-
5 Finlay J M, Zigmond M J.
A critical analysis of neurochemical methods for monitoring transmitter dynamics in the brain. In: BloomE, DJ Kupfer (eds) The fourth generation of progress. New York; Raven Press 1995: pp. 29-40 - 6 Graef F G, Viana M B, Mora P O. Opposed regulation by dorsal raphe nucleus 5-HT pathway of two types of fear in the elevated T-maze. Pharmacol Biochem Behav. 1996; 53 171-177
- 7 Handley S L, McBlane W. Serotonin mechanisms in animal models of anxiety. Braz J Med Biol Res. 1993; 26 1-13
- 8 Harro J, Oreland L. Depression as a spreading neuronal adjustment disorder. Eur Neuropharmacol. 1996; 6 207-223
-
9 Kaehler S T, Sinne C r, Chatterjee S S, Philippu A. Effects of hyperforin-free hypericum extract on transmitter release in the rat locus coeruleus (submitted).
- 10 Kaehler S T, Sinner C, Chatterjee S S, Philippu A. Hyperforin enhances the extracellular concentrations of catecholamines, serotonin and glutamate in the rat locus coeruleus. Neurosci Lett. 1999a; 262 199-202
- 11 Kaehler S T, Singewald N, Philippu A. The release of catecholamines in hypothalamus and locus coeruleus is modulated by peripheral chemoreceptors. Naunyn-Schmiedeberg's Arch Pharmacol. 1999b; 360 428-434
- 12 Kaehler S T, Sinner C, Kouvelas D, Philippu A. Effects of inescapable shock and conditioned fear on the release of excitatory and inhibitory amino acids in the locus coeruleus. Naunyn-Schmiedeberg's Arch Pharmacol. 2000a; 361 193-199
- 13 Kaehler S T, Singewald N, Sinner C, Thurnher C, Philippu A. Conditioned fear and inescapable shock modify the release of serotonin in the locus coeruleus. Brain Res. 2000b; 859 249-254
-
14 Maier S F.
Learned helplessness: relationships with fear and anxiety. In: StanfordC, P Salmon (eds) Stress: From synapse to syndrome. Orlando; Academic Press 1993: pp. 207-248 - 15 Müller W E, Rolli M, Schäfer C, Hafner U. Effects of hypericum extract (LI 160) in biochemical models of antidepressant actvity. Pharmaco- psychiatry. 1997; 30 ((Suppl. 2)) 102-107
- 16 Müller W E, Chatterjee S S. Hyperforin and the antidepressant activity of St. John's Wort. Pharmacophychiatry 1998: 1-60
- 17 Myers R D, Adell A, Lankford M F. Simultaneous comparison of cerebral dialysis and push-pull perfusion in the brain of rats: a critical review. Neurosci Biobiobehav Rev. 1998; 22 371-387
- 18 Perovic S, Müller W EG. Pharmacological profile of hypericum extract. Arzneim Forsch/Drug Res. 1995; 45 1145-1148
-
19 Philippu A.
Use of push-pull cannulae to determine the release of endogenous neurotransmitters in distinct brain areas of anaesthetized and freely moving animals. In: Marsden CA (ed.) Measurement of neurotransmitter release in vivo. Chichester; John Wiley 1984: pp. 3-37 - 20 Philippu A. Analysis of hypothalamic transmitter release during cardiocascular cardiovascular changes. Ann NY Acad Sci. 1985a; 472 140-150
-
21 Philippu A.
The use of push-pull cannulae for superfusing various hypothalamic areas in anaesthetized and conscious, freely moving animals. In: Bayon A, R Drucker-Colin (eds.) In vivo perfusion and release of neuroactive substances. Methods and strategies. Orlando; Academic Press 1985b: pp. 221-232 - 22 Philippu A. Regulation of blood pressure by central neurotransmitters and neuropeptides. Rev Biochem Pharmacol. 1988; 111 1-115
- 23 Philippu A, Prast H, Singewald N. Identification and dynamics of neuronal modulation and function in brain structures and nuclei by continuous determination of transmitter release rates using the push-pull superfusion technique: a compelling approach to in vivo brain research. Sci Pharm. 1996; 64 609-618
- 24 Przuntek H, Philippu A. Reduced pressor responses to stimulation of the locus coeruleus after lesion of the posterior hypothalamus. Naunyn-Schmiedeberg's Arch Pharmacol. 1993; 276 119-122
- 25 Rolli M, Schäfer C, Müller W E. Effect of hypericum extract (LI 160) on neurotransmitter receptor binding and synaptosomal uptake systems. Pharmacopsychiatry. 1995; 28 207
- 26 Schneider C, Singewald N, Philippu A. Inhibition of catecholamine (norepinephrine, dopamine) release in the locus coeruleus and the hypothalamus by baroreceptor activation: identification of the involved baroreceptors. Naunyn-Schmiedeberg¿s Arch Pharmacol. 1995; 352 291-296
- 27 Singewald N, Guo L J, Schneider C, Kaehler S, Philippu A. Serotonin outflow in the hypothalamus of conscious rats: origin and possible involvement in cardiovascular control. Eur J Pharnacol. 1995; 294 787-793
- 28 Singewald N, Philippu A. Catecholamine release in the locus coeruleus is modified by experimentally induced changes in haemodynamics. Naunyn-Schmiedeberg¿s Arch Pharmacol. 1993; 347 356-363
- 29 Singewald N, Philippu A. Involvement of biogenic amines in the central regulation of cardiovascular homeostasis. Trends Pharmacol Sci. 1996; 17 356-363
- 30 Singewald N, Kaehler S, Hemeida R, Philippu A. Release of serotonin in the rat locus coeruleus: Effect(s) of cardiovascular, stressful and noxious stimuli. Eur J Neurosci. 1997a; 9 556-562
- 31 Singewald N, Kouvelas D, Chen F, Philippu A. The release of inhibitory amino acids in the hypothalamus is tonically modified by impulses from aortic baroreceptors as a consequence of blood pressure fluctuations. Naunyn-Schmiedeberg¿s Arch Pharmacol. 1997b; 356 348-355
- 32 Singewald N, Philippu A. Release of neurotransmitters in the locus coeruleus. Progr Neurobiol. 1998; 56 237-267
- 33 Singewald N, Kouvelas D, Kaehler S T, Sinner C, Philippu A. Peripheral chemoreceptor activation enhances 5-HT release in the locus coeruleus of conscious rats. Neurosc Lett 2000:
- 34 Stricker-Krongrad A, Beck B, Burlet C. Microdialysis and push-pull Supefusion to estimate hypothalamic paraventricular neurpeptide Y release. 6th International conference on in vivo Methods 1994: 354-355
- 35 Timmerman W, Westerink B HC. Brain microdialysis of GABA and glutamate: what does it signify?. Synapse. 1997; 27 242-261
Athineos Philippu
Department of Pharmacology and Toxicology
University of Innsbruck
Peter-Mayr-Strasse 1
6020 Innsbruck
Austria